Skip to content
MedsAcross

Medicine

Gonal-f RFF Redi-ject 300 IU/0.5 mL injection

Follitropin · Subcutaneous · EMD Serono
Available on requestPrescription onlyUS FDA Cold chain

Gonal-f RFF Redi-ject 300 IU/0.5 mL injection is a prescription medicine containing Follitropin for subcutaneous use, marketed by EMD Serono, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Refrigerate at 2°C to 8°C (36°F to 46°F) until the expiration date, or store…

Key facts

Active ingredient (INN)
Follitropin
Brand
Gonal-f RFF Redi-ject
Strength
300 IU/0.5 mL
Dosage form
Injection
Route
Subcutaneous
Packs
1 package
Marketing authorisation holder
EMD Serono
Manufacturer
EMD Serono
Origin register
US FDA, United States
Storage
Refrigerate at 2°C to 8°C (36°F to 46°F) until the expiration date, or store at room temperature at 20° to 25°C (68°F to 77°F) for up to three months or until the expiration date, whichever occurs first.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.39Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
16 October 2013
Identifiers
RxCUI 1594334, 1594418, 1594432 +3DailyMed set ID b6d11c45-b502-478e-bb28-2ff596ea259cNDC 44087-1116, 44087-1115, 44087-1117Application BLA021684

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 package in 1 carton / .5 mL in 1 package44087-1115-1EMD Serono16 October 2013
1 package in 1 carton / .75 mL in 1 package44087-1116-1EMD Serono16 October 2013
1 package in 1 carton / 1.5 mL in 1 package44087-1117-1EMD Serono16 October 2013

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Follitropin

Clinical summary

Follitropin is a gonadotropin indicated for fOLLISTIM AQ Cartridge is a gonadotropin indicated, among other approved uses. It is available as injection for subcutaneous use. MedsAcross supplies Follitropin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Follitropin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Gonal-f RFF Redi-ject 300 IU/0.5 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.